ReviewFrontiers in immunology2026

The dawn of the dual-target era in respiratory disease: promise, pitfalls, and a roadmap for bispecific antibodies.

Yikun Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.